{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of DJ-1 function contributes to neuronal cell death in AR-EOP with mutant DJ-1.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that loss of DJ-1 function causes the AR-EOP phenotype, and the L166P mutation is associated with this loss."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used oxidative stress, ER stress, and proteasome inhibition assays to model DJ-1's protective role.",
          "judgment": "Yes",
          "reasoning": "The assays (cell death under oxidative/ER stress, proteasome inhibition) directly model the loss-of-protective-function mechanism of DJ-1 in AR-EOP.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type DJ-1 and L166P mutant DJ-1 were overexpressed to compare functional outcomes.",
          "judgment": "No",
          "reasoning": "While wild-type and mutant controls were used, the paper does not explicitly state multiple replicates (e.g., 'n=3 independent experiments')."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The assays (cell death rescue under oxidative stress, ER stress) are standard in studying DJ-1's neuroprotective role.",
          "judgment": "Yes",
          "reasoning": "The assays align with prior studies validating DJ-1's protective function against oxidative/ER stress and proteasome inhibition.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "No statistical tests or p-values are explicitly reported for the L166P variant's functional data.",
          "judgment": "No",
          "reasoning": "The absence of statistical analysis prevents estimation of OddsPath for this variant."
        },
        {
          "step_name": "Step 4b: Total variant controls",
          "extracted_paper_info": "Only two variants were tested: wild-type DJ-1 and L166P mutant DJ-1.",
          "judgment": "Yes",
          "reasoning": "Since â‰¤10 total benign/pathogenic controls were used, the evidence strength is capped.",
          "next_step_or_outcome": "Finalize strength as PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting",
      "overall_conclusion": "The L166P variant in DJ-1 demonstrates loss of protective function under oxidative/ER stress and proteasome inhibition, supporting its pathogenicity in AR-EOP. The evidence is classified as PS3_supporting due to limited statistical analysis and small control variant set."
    }
  ]
}